Ligand Pharma (LGND) PT Raised to $260 at BofA Securities

April 27, 2026 2:55 PM

BofA Securities analyst Jason Zemansky raised the price target on Ligand Pharma (NASDAQ: LGND) to $260.00 (from $250.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found